Platelets, key facilitators of primary hemostasis and thrombosis, have emerged as crucial cellular mediators of innate immunity and inflammation. Exemplified by their ability to alter the phenotype and function of monocytes, activated platelets bind to circulating monocytes to form monocyte-platelet aggregates (MPA). The platelet-monocyte axis has emerged as a key mechanism connecting thrombosis and inflammation. MPA are elevated across the spectrum of inflammatory and autoimmune disorders, including cardiovascular disease, systemic lupus erythematosus (SLE), and COVID-19, and are positively associated with disease severity. These clinical disorders are all characterized by an increased risk of thromboembolic complications. Intriguingly, monocytes in contact with platelets become proinflammatory and procoagulant, highlighting that this interaction is a central element of thromboinflammation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225702PMC
http://dx.doi.org/10.3389/fcvm.2023.960398DOI Listing

Publication Analysis

Top Keywords

platelet-monocyte aggregates
4
aggregates molecular
4
molecular mediators
4
mediators thromboinflammation
4
thromboinflammation platelets
4
platelets key
4
key facilitators
4
facilitators primary
4
primary hemostasis
4
hemostasis thrombosis
4

Similar Publications

Background: Although rare, vaccine-induced thrombotic thrombocytopenia (VITT) following adenoviral vector COVID-19 vaccination is a concerning and often severe adverse effect of vaccination. The generation of high antiplatelet factor 4 antibody titers promotes the formation of immune complexes capable of activating platelets and neutrophils through FcγRIIa.

Objectives: Given that platelet-leukocyte aggregate formation and inflammasome activation are common features of thromboinflammatory diseases, we aimed to evaluate if these are also features of VITT.

View Article and Find Full Text PDF

Downregulation of cardiac inflammation via the CaMKII δ/NF-κB pathway in heart failure by Lonicerae Japonicae Flos and Angelicae Sinensis Radix.

Phytomedicine

January 2025

School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China; Chinese Medicine Syndrome and Formula, Beijing University of Chinese Medicine, Beijing 102488, China. Electronic address:

Background: Inflammation serves an essential function in the occurrence and progression of heart failure (HF), especially in the early stage. Lonicerae japonicae Flos (LJF), Angelicae sinensis Radix (ASR), and their compatibility (LJF+ASR) can inhibit excessive inflammation and have significant cardioprotective effects. However, the primary active ingredients and mechanism of LJF and ASR in anti-inflammatory and anti-HF effect remain to be elucidated.

View Article and Find Full Text PDF

Background And Aims: Acute coronary syndrome (ACS) is one of the most important cardiovascular diseases. The rupture of atherosclerotic plaques in coronary arteries is considered the underlying pathophysiology of ACS. The interaction between cytokines and leukocytes in the presence of platelets results in platelet-leukocyte aggregate (PLA).

View Article and Find Full Text PDF

Platelet-Monocyte Aggregate Instigates Inflammation and Vasculopathy in Kawasaki Disease.

Adv Sci (Weinh)

December 2024

Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, China.

Article Synopsis
  • Kawasaki disease (KD) is an acute illness in young children that leads to serious heart complications, primarily through platelet hyperactivity and an abnormal immune response.
  • Researchers identified a feedback loop involving platelets and monocytes, where their interaction activates inflammatory processes that worsen KD symptoms.
  • Targeting specific proteins and cytokines in this feedback loop could offer new diagnostic and treatment strategies for managing the vascular damage caused by KD.
View Article and Find Full Text PDF

Mac-1 Alongside Platelet-Monocyte Aggregates as Potential Markers in Acute Coronary Syndrome: A Case-Control Study.

Cell J

September 2024

Hematopoietic Stem Cell Research Centre, Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email:

Objective: Cardiovascular diseases (CVDs) are the leading cause of death worldwide, with atherosclerosis serving as a primary factor in their development. Platelets, leukocytes, and their interactions play a crucial role in initiating and amplifying atherosclerosis. This study aims to evaluate the levels of platelet-monocyte aggregates (PMA) and specific integrins involved in leukocyte recruitment, including macrophage-1 antigen (Mac-1) and lymphocyte functionassociated antigen-1 (Lfa-1), in patients with acute coronary syndrome (ACS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!